Mechanisms in CME

CME Module Index

Module 1: The Modern Diagnostic Work-Up of Multiple Myeloma and Related Disorders Module 1: The Modern Diagnostic Work-Up of Multiple Myeloma and Related Disorders

Multiple myeloma is a malignant plasma-cell proliferative disorder with an expected 19,920 new cases and 10,690 deaths in the United States in 2008

CME Credits
1.25 AMA PRA
Category 1 Credits™

Module 2: Myeloma Bone Disease: Pathogenesis, Diagnosis, and Treatment Module 2: Myeloma Bone Disease: Pathogenesis, Diagnosis, and Treatment

Patients with multiple myeloma commonly experience skeletal-related complications that are a result of a shift in the normal balance between bone formation

CME Credits
1.00 AMA PRA
Category 1 Credits™

Module 3: Management of Multiple Myeloma: Risk Factors and Treatment Strategies Module 3: Management of Multiple Myeloma: Risk Factors and Treatment Strategies

The initial evaluation of the patient with symptomatic multiple myeloma (MM) must establish whether the disease is symptomatic, hence requiring therapy

CME Credits
3.00 AMA PRA
Category 1 Credits™

Module 4: Novel Anticancer Agents and Their Clinical Implications Module 4: Novel Anticancer Agents and Their Clinical Implications

For decades, chemotherapy for multiple myeloma has consisted of standard combinations of alkylating agents, anthracyclines, and steroids

CME Credits
1.00 AMA PRA
Category 1 Credits™

Module 5: Amyloidosis, POEMS, and Castleman Disease Module 5: Amyloidosis, POEMS, and Castleman Disease

Amyloidosis represents a group of disorders caused by abnormal folding, aggregation, and accumulation of certain precursor proteins in the tissues.

CME Credits
1.25 AMA PRA
Category 1 Credits™

Module 6: Waldenström’s Macroglobulinemia Module 6: Waldenström’s Macroglobulinemia

Waldenström’s macroglobulinemia (WM) is a distinct clinicopathological entity characterized primarily by bone marrow infiltration with clonally related lymphocytes

CME Credits
0.75 AMA PRA
Category 1 Credits™